Stek advises shareholders of CAM Bioceramics in sale of majority stake to SHS Capital and ING Corporate Investments

The shareholders of CAM Bioceramics have sold a majority stake to SHS Capital, a German investor specialising in healthcare, and ING Corporate Investments and will remain involved as minority shareholders.

Bioceramics, based in Leiden, the Netherlands, is a leading global producer of innovative calcium phosphate solutions for Medtech and LifeScience applications.

Click here for the press release.

Lawyers

Practice Areas

This might also interest you

Stek successful for Liander in transport capacity dispute

Read more

Stek advises Egeria on its intended acquisition of IT-company Superp

Read more

Stek advises Stedin on EUR 500 million equity investment by the Dutch State.

Read more